B2M and chronic kidney disease: Our observations suggest that B2M or CysC can be used to obtain an estimate of eGFR when the latter is in the hyperfiltration range, thus completing the suggested use of these alternative biomarkers when eGFR creatinine is in the 40-60 mL/min/1.73 m2 range and CKD diagnosis confirmation is needed studies39.